Low‐dose adjuvant dexmedetomidine did not decrease propofol sedation requirements in children undergoing gastrointestinal endoscopy
Authors:
- 23 September 2022
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 42 (10) , 792-797
Abstract
Background: Propofol is the cornerstone of deep sedation during pediatric esophagogastroduodenoscopy (EGD), though adjuvant dexmedetomidine may provide propofol‐sparing benefits.Objective: The objective of the study was to evaluate whether adjuvant dexmedetomidine decreases the total propofol dose in pediatric patients undergoing EGD.Methods: This single‐center, retrospective, cohort study evaluated the total propofol dose in pediatric patients undergoing EGD with and without the use of adjuvant dexmedetomidine. Secondary outcomes included the change in hemodynamics across the perioperative continuum and post‐procedure recovery time. A multivariable general linear regression was performed to identify associated variables for recovery time post‐procedure.Results: A total of 159 patients were included in the study; 88 patients received dexmedetomidine and propofol (DEX‐PRO), and 71 patients received propofol only (PRO). The median [interquartile range (IQR)] propofol dose in the DEX‐PRO group was 0.26 [IQR, 0.17–0.36] mg kg−1 min−1 which was not significantly different than the PRO group at 0.27 [IQR, 0.21–0.34] mg kg−1 min−1, p = 0.730. Evaluation of secondary end points showed the DEX‐PRO group had more cases of post‐anesthesia care unit (PACU) hypotension (61% vs. 34%, p = 0.001) and a longer recovery time (32.9 ± 14.1 vs. 25.6 ± 10.8 min, p < 0.001) versus the PRO group, respectively. Multivariable linear regression demonstrated that age and the use of dexmedetomidine were associated with prolonged recovery.Conclusion: Adjuvant dexmedetomidine did not reduce propofol requirements compared with propofol alone in pediatric patients undergoing EGD. More hypotension and a longer postoperative recovery time were also seen in patients receiving adjuvant dexmedetomidine for their endoscopic procedure.Keywords
This publication has 17 references indexed in Scilit:
- Pediatric Critical Care Physician-Administered Procedural Sedation Using PropofolPediatric Critical Care Medicine, 2015
- Comparison of propofol and dexmedetomedine techniques in children undergoing magnetic resonance imagingPediatric Anesthesia, 2014
- Dexmedetomidine Reduces Propofol and Remifentanil Requirements During Bispectral Index-Guided Closed-Loop AnesthesiaAnesthesia & Analgesia, 2014
- Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care UnitCritical Care Medicine, 2013
- Safe and Effective Procedural Sedation for Gastrointestinal Endoscopy in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2012
- The Incidence and Nature of Adverse Events During Pediatric Sedation/Anesthesia With Propofol for Procedures Outside the Operating Room: A Report From the Pediatric Sedation Research ConsortiumAnesthesia & Analgesia, 2009
- Determination of the pharmacodynamic interaction of propofol and dexmedetomidine during esophagogastroduodenoscopy in childrenPediatric Anesthesia, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Propofol for procedural sedation in children in the emergency departmentAnnals of Emergency Medicine, 2003
- Pharmacokinetics of propofol when given by intravenous infusion.British Journal of Clinical Pharmacology, 1990